Patient-reported acute GI symptoms in locally advanced cervical cancer patients correlate with rectal dose

In the treatment of locally advanced cervical cancer (LACC) patients, the current treatment of choice is the administration of external beam radiotherapy (EBRT) with concomitant chemotherapy and image-guided adaptive brachytherapy. Research has shown that this patient group suffers from a variety of side effects caused by the treatment. Patients report, among others, gastrointestinal (GI) toxicity, genitourinary (GU) toxicity and overall decrease in quality of life (QoL) in both the acute and late phase after treatment [1].
Source: Radiotherapy and Oncology - Category: Radiology Authors: Tags: Original Article Source Type: research